Summit X, LLC United Therapeutics Corp Transaction History
Summit X, LLC
- $383 Million
- Q1 2024
Shares
2 transactions
Others Institutions Holding UTHR
# of Institutions
562Shares Held
43.1MCall Options Held
501KPut Options Held
529K-
Black Rock Inc. New York, NY5.57MShares$1.83 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.68MShares$1.54 Billion0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.41MShares$1.12 Billion0.14% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.86MShares$941 Million7.91% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.15MShares$708 Million0.78% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $15B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...